O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy

International Journal of Molecular Medicine

Volumn 33, Issue 3, 2014, Pages 624-632

  Xu, Chong ^a   Liu, Guodong ^a   Liu, Xiaoqiao ^a   Wang, Fang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Blood retinal barrier; Diabetic retinopathy; Hypoxia; O GlcNAcylation; Occludin

Indexed keywords

ACETYLGLUCOSAMINE; ANIMALS; ANOXIA; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINA; RETINAL PIGMENT EPITHELIUM;

EID: 84893850202     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1597     Document Type: Article

References (49)

1. Torres CR and Hart GW: Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259: 3308-3317, 1984.
2. Hart GW, Housley MP and Slawson C: Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022, 2007.
3. Lima VV, Rigsby CS, Hardy DM, Webb RC and Tostes RC: O-GlcNAcylation: A novel post-translational mechanism to alter vascular cellular signaling in health and disease: Focus on hypertension. J Am Soc Hypertens 3: 374-387, 2009.
4. Lima VV, Spitler K, Choi H, Webb RC and Tostes RC: O-GlcNAcylation and oxidation of proteins: Is signalling in the cardiovascular system becoming sweeter? Clin Sci (Lond) 123: 473-486, 2012.
5. Lima VV, Giachini FR, Carneiro FS, et al: Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli-VASOACTIVE PEPTIDE SYMPOSIUM. J Am Soc Hypertens 2: 410-417, 2008.
6. Kim do H, Seok YM, Kim IK, Lee IK, Jeong SY and Jeoung NH: Glucosamine increases vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aorta. BMB Rep 44: 415-420, 2011.
7. Grimm C and Willmann G: Hypoxia in the eye: A two-sided coin. High Alt Med Biol 13: 169-175, 2012.
8. Banumathi E, Haribalaganesh R, Babu SS, Kumar NS and Sangiliyandi G: High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. Microvasc Res 77: 377-381, 2009.
9. Ali TK and El-Remessy AB: Diabetic retinopathy: Current management and experimental therapeutic targets. Pharmacotherapy 29: 182-192, 2009.
10. Ruan HB, Singh JP, Li MD, Wu J and Yang X: Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab 24: 301-309, 2013.
11. Jensen RV, Zachara NE, Nielsen PH, Kimose HH, Kristiansen SB and Botker HE: Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res 97: 369-378, 2013.
12. Bennett CE, Johnsen VL, Shearer J and Belke DD: Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice. Life Sci 92: 657-663, 2013.
13. McLarty JL, Marsh SA and Chatham JC: Post-translational protein modification by O-linked N-acetyl-glucosamine: Its role in mediating the adverse effects of diabetes on the heart. Life Sci 92: 621-627, 2013.
14. Gurel Z, Sieg KM, Shallow KD, Sorenson CM and Sheibani N: Retinal O-linked N-acetylglucosamine protein modifications: Implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Mol Vis 19: 1047-1059, 2013.
15. Zachara NE, Molina H, Wong KY, Pandey A and Hart GW: The dynamic stress-induced 'O-GlcNAc-ome' highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids 40: 793-808, 2011.
16. Tai TC, Wong-Faull DC, Claycomb R and Wong DL: Hypoxic stress-induced changes in adrenergic function: Role of HIF1 alpha. J Neurochem 109: 513-524, 2009.
17. Witt KA, Mark KS, Huber J and Davis TP: Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem 92: 203-214, 2005.
18. Arden GB and Sivaprasad S: Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev 7: 291-304, 2011.
19. Li C, Chen P, Zhang J, et al: Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1alpha pathway. Invest Ophthalmol Vis Sci 54: 4964-4970, 2013.
20. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD and Hart GW: Dynamic O-GlcNAc modification of nucleocy-toplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279: 30133-30142, 2004.
21. Arvanitis LD, Vassiou K, Kotrotsios A and Sgantzos MN: Hypoxia upregulates the expression of the O-linked N-acetylglucosamine containing epitope H in human ependymal cells. Pathol Res Pract 207: 91-96, 2011.
22. Ngoh GA, Watson LJ, Facundo HT, Dillmann W and Jones SP: Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 45: 313-325, 2008.
23. Ngoh GA, Facundo HT, Zafir A and Jones SP: O-GlcNAc signaling in the cardiovascular system. Circ Res 107: 171-185, 2010.
24. Araki E, Oyadomari S and Mori M: Endoplasmic reticulum stress and diabetes mellitus. Intern Med 42: 7-14, 2003.
25. Harding HP, Zeng H, Zhang Y, et al: Diabetes mellitus and exocrine pancreatic dysfunction in perk-/-mice reveals a role for translational control in secretory cell survival. Mol Cell 7: 1153-1163, 2001.
26. Ozcan U, Cao Q, Yilmaz E, et al: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004.
27. Jones SP, Zachara NE, Ngoh GA, et al: Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117: 1172-1182, 2008.
28. Liu J, Marchase RB and Chatham JC: Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 293: H1391-H1399, 2007.
29. Ngoh GA, Facundo HT, Hamid T, Dillmann W, Zachara NE and Jones SP: Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ Res 104: 41-49, 2009.
30. Champattanachai V, Marchase RB and Chatham JC: Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294: C1509-C1520, 2008.
31. Ngoh GA, Hamid T, Prabhu SD and Jones SP: O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am J Physiol Heart Circ Physiol 297: H1711-H1719, 2009.
32. Hanover JA, Krause MW and Love DC: The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 1800: 80-95, 2010.
33. Guinez C, Mir AM, Leroy Y, Cacan R, Michalski JC and Lefebvre T: Hsp70-GlcNAc-binding activity is released by stress, proteasome inhibition, and protein misfolding. Biochem Biophys Res Commun 361: 414-420, 2007.
34. Kennedy A and Frank RN: The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells. Curr Eye Res 36: 168-177, 2011.
35. Loukovaara S, Koivunen P, Ingles M, Escobar J, Vento M and Andersson S: Elevated protein carbonyl and HIF-1alpha levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol: May 29, 2013 (Epub ahead of print).
36. Yu DY and Cringle SJ: Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20: 175-208, 2001.
37. Yu DY, Cringle SJ, Yu PK and Su EN: Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci 48: 2290-2296, 2007.
38. Cringle SJ and Yu DY: A multi-layer model of retinal oxygen supply and consumption helps explain the muted rise in inner retinal PO(2) during systemic hyperoxia. Comp Biochem Physiol A Mol Integr Physiol 132: 61-66, 2002.
39. Yu DY, Cringle SJ and Su EN: Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia. Invest Ophthalmol Vis Sci 46: 4728-4733, 2005.
40. Sandercoe TM, Geller SF, Hendrickson AE, Stone J and Provis JM: VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: Evidence of developmental hypoxia. J Comp Neurol 462: 42-54, 2003.
41. Semenza GL: Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 19: 176-182, 2004.
42. Bensellam M, Duvillie B, Rybachuk G, et al: Glucose-induced O(2) consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One 7: E29807, 2012.
43. Yang L, Tan P, Zhou W, et al: N-acetylcysteine protects against hypoxia mimetic-induced autophagy by targeting the HIF-1 alpha pathway in retinal ganglion cells. Cell Mol Neurobiol 32: 1275-1285, 2012.
44. Feldman GJ, Mullin JM and Ryan MP: Occludin: Structure, function and regulation. Adv Drug Deliv Rev 57: 883-917, 2005.
45. Cummins PM: Occludin: One protein, many forms. Mol Cell Biol 32: 242-250, 2012.
46. Dorfel MJ and Huber O: Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol 2012: 807356, 2012.
47. Clarke H, Soler AP and Mullin JM: Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci 113 (Pt 18): 3187-3196, 2000.
48. Simonovic I, Arpin M, Koutsouris A, Falk-Krzesinski HJ and Hecht G: Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function. Infect Immun 69: 5679-5688, 2001.
49. Butt AM, Feng D, Nasrullah I, et al: Computational identification of interplay between phosphorylation and O-beta-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry. Infect Genet Evol 12: 1235-1245, 2012.